Conclusions The findings of this meta-analysis of seven RCTs (6609 participants) suggest a dose-dependent superiority of all three tirzepatide maintenance doses on glycaemic control, not only vs placebo but also vs long-acting GLP-1 RAs and basal insulin regimens
Utilising our expertise and experience in medication adherence and patient compliance we acquire, monitor, analyse, guide and interpret data to deliver absolute clarity and bring confidence to sponsors, trialists, and ultimately, patients
These can include nausea, vomiting, diarrhoea, and abdominal cramps
Stomach acid and a protein called intrinsic factor (IF) aid in B12 absorption
In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet
Isolation of rat renal NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase